Yale School of Medicine
A

Sex-specific Risk Factors and Approach in Cardiovascular Disease

By Yale School of Medicine FEATURING Athena Poppas
May 24, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

11:40
Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal Insulin

Feat. C. Wierum, L. Coco

Featured Video

08:19
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head Trial …

Feat. R. Pratley

Related Content

AUTOPLAY
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Acids…

Feat. R. Mason
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effective Is t…

Feat. D. Bhatt
14:28
The North American Thrombosis Forum (NATF)

Thrombosis and Hypercoagulable States in Young Women: How to Manage VTE Ri…

Feat. G. Piazza
18:33
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Clinical Presentations and Risk Factors of Peripartum Cardiomyopathy

Feat. U. Elkayam
09:13
Houston Methodist DeBakey Heart and Vascular Center

SCAD & Pregnancy: What Is It, What Are the Causes, and When Does It Oc…

Feat. M. Tweet
42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How To Trea…

Feat. A. Klein
19:00
Yale School of Medicine

Hypertension in Pregnancy: Risk Factors, Diagnosis and Treatment Options

Feat. M. Jane Minkin
12:08
Houston Methodist DeBakey Heart and Vascular Center

Are All Carbs and Fats Created Equally, and What Influence Do Different Ca…

Feat. A. Agatston
35:57
37th Annual Advances in Heart Disease

Updates in Preoperative Evaluation in Patients Undergoing Non-cardiac Surg…

Feat. R. Eshima Mckay
11:59
Houston Methodist DeBakey Heart and Vascular Center

Does Measuring and Lowering Lp(a) Affect CVD Risk Reduction?

Feat. R. Blankstein
57:22
3M+KCI

Surgical Site Infections Reduction Strategies in Vascular Surgery from Sta…

Feat. R. C. Prielipp, E. Dillavou
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

14:52
Richard Pratley

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

15:14
Cardiometabolic Health Congress (CMHC)

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is the Corr…

Feat. D. Bhatt
07:11
Houston Methodist DeBakey Heart and Vascular Center

Who Should Get a Coronary Artery Calcium Test?

Feat. K. Nasir
10:01
Cardiometabolic Health Congress (CMHC)

Who Is an Obesity Medicine Specialist, and Why?

Feat. H. Bays
30:58
ASPC 2019 Congress on CVD Prevention

Tobacco Cessation and Cardiovascular Hazards of Vaping

Feat. P. Morris
23:23
Yale School of Medicine

Highlights of North American Menopause Society (NAMS) 2021 Annual Meeting

Feat. M. Jane Minkin
13:19
Houston Methodist DeBakey Heart and Vascular Center

What Are the Key Components of Primary CVD Prevention from ACC/AHA Guideli…

Feat. S. Virani
24:25
Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease Management: What Are the Strategies to Slow the Pr…

Feat. R. Agarwal